Inhalation Sciences ships major order worth approx. 3 MSEK to new US big pharma client
Inhalation Sciences (ISAB) has shipped a major order, originally announced in December 2019, to a big pharma client in the US. The order includes a PreciseInhale[®] aerosol generator and a DissolvIt[®] in vitro tool, the third such module to ship within weeks of its recent commercial launch.“The preliminary revenue numbers for Q1, including this shipment, is 5,7 MSEK. This would mean the best quarter in ISAB’s history from a revenue point of view” says ISAB CEO Manoush Masarrat, “for our team to realize this shipment now, despite the present uncertainties and challenges over COVID-19,